(Q22008623)

GOA release 2020-03-11

G Wu

1

G

Wu

1 reference

7 February 2023

T Hayashi

2

T

Hayashi

1 reference

7 February 2023

J H Park

3

J H

Park

1 reference

7 February 2023

M Dixit

4

M

Dixit

1 reference

7 February 2023

D M Reynolds

5

D M

Reynolds

1 reference

7 February 2023

L Li

6

L

Li

1 reference

7 February 2023

Y Maeda

7

Y

Maeda

1 reference

7 February 2023

Y Cai

8

Y

Cai

1 reference

7 February 2023

M Coca-Prados

9

M

Coca-Prados

1 reference

7 February 2023

S Somlo

10

S

Isolated polycystic liver disease as a distinct genetic disease, unlinked to polycystic kidney disease 1 and polycystic kidney disease 2

Somlo

1 reference

7 February 2023

language of work or name

English

0 references

publication date

15 December 1998

0 references

published in

Genomics

0 references

volume

54

0 references

page(s)

564-8

0 references

issue

3

0 references

cites work

1 reference

https://api.crossref.org/works/10.1006%2FGENO.1998.5618

7 January 2021

Characterization of the exon structure of the polycystic kidney disease 2 gene (PKD2)

1 reference

https://api.crossref.org/works/10.1006%2FGENO.1998.5618

7 January 2021

Genetic heterogeneity of polycystic kidney disease in Bulgaria.

1 reference

https://api.crossref.org/works/10.1006%2FGENO.1998.5618

7 January 2021

Autosomal dominant polycystic kidney disease: evidence for the existence of a third locus in a Portuguese family

1 reference

https://api.crossref.org/works/10.1006%2FGENO.1998.5618

7 January 2021

Evidence for a third genetic locus for autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1006%2FGENO.1998.5618

7 January 2021

The prostaglandin transporter is widely expressed in ocular tissues.

1 reference

https://api.crossref.org/works/10.1006%2FGENO.1998.5618

7 January 2021

trp, a novel mammalian gene family essential for agonist-activated capacitative Ca2+ entry

1 reference

https://api.crossref.org/works/10.1006%2FGENO.1998.5618

7 January 2021

Somatic inactivation of Pkd2 results in polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1006%2FGENO.1998.5618

7 January 2021

The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type I.

1 reference

https://api.crossref.org/works/10.1006%2FGENO.1998.5618

7 January 2021

A new bacteriophage P1-derived vector for the propagation of large human DNA fragments

1 reference

https://api.crossref.org/works/10.1006%2FGENO.1998.5618

7 January 2021

PKD1 interacts with PKD2 through a probable coiled-coil domain

1 reference

https://api.crossref.org/works/10.1006%2FGENO.1998.5618

7 January 2021

Mapping of the gene for autosomal recessive polycystic kidney disease (ARPKD) to chromosome 6p21-cen

1 reference

https://api.crossref.org/works/10.1006%2FGENO.1998.5618

7 January 2021

Homo- and heterodimeric interactions between the gene products of PKD1 and PKD2

1 reference

https://api.crossref.org/works/10.1006%2FGENO.1998.5618

7 January 2021

Identification and characterization of polycystin-2, the PKD2 gene product

1 reference

https://api.crossref.org/works/10.1006%2FGENO.1998.5618

7 January 2021

Isolation of a new clathrin heavy chain gene with muscle-specific expression from the region commonly deleted in velo-cardio-facial syndrome

1 reference

https://api.crossref.org/works/10.1006%2FGENO.1998.5618

7 January 2021

PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein

1 reference

https://api.crossref.org/works/10.1006%2FGENO.1998.5618

7 January 2021